These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27315460)

  • 1. Investigation of the ototoxicity of gadoteridol (ProHance) and gadodiamide (Omniscan) in mice.
    Nonoyama H; Tanigawa T; Shibata R; Tanaka H; Katahira N; Horibe Y; Takemura K; Murotani K; Ozeki N; Ueda H
    Acta Otolaryngol; 2016 Nov; 136(11):1091-1096. PubMed ID: 27315460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diluted gadoteridol (ProHance®) causes mild ototoxicity in cochlear outer hair cells.
    Katahira N; Tanigawa T; Tanaka H; Nonoyama H; Ueda H
    Acta Otolaryngol; 2013 Aug; 133(8):788-95. PubMed ID: 23638948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the biological effects of gadodiamide (Omniscan) and gadoteridol (ProHance) by means of multi-organ and plasma metabolomics.
    Romano F; Di Gregorio E; Riccardi G; Furlan C; Cavallini N; Savorani F; Di Porzio A; De Tito S; Randazzo A; Gianolio E; Iaccarino N
    Analyst; 2023 May; 148(11):2415-2424. PubMed ID: 37092509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
    Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
    Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profiles of gadolinium chelates in juvenile rats differ according to the risk of dissociation.
    Fretellier N; Maazouz M; Luseau A; Baudimont F; Jestin-Mayer G; Bourgery S; Rasschaert M; Bruneval P; Factor C; Mecieb F; Idée JM; Corot C
    Reprod Toxicol; 2014 Dec; 50():171-9. PubMed ID: 25462783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the ototoxicity of almond oil in a chinchilla animal model.
    Peleva E; Mourad S; Citra D; Daniel SJ
    Laryngoscope; 2011 Dec; 121(12):2661-4. PubMed ID: 22109768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media.
    Runge VM; Dickey KM; Williams NM; Peng X
    Invest Radiol; 2002 Jul; 37(7):393-8. PubMed ID: 12068161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart.
    Akre BT; Dunkel JA; Hustvedt SO; Refsum H
    Acad Radiol; 1997 Apr; 4(4):283-91. PubMed ID: 9110026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gd accumulation in tissues of healthy mice upon repeated administrations of Gadodiamide and Gadoteridol.
    Di Gregorio E; Iani R; Ferrauto G; Nuzzi R; Aime S; Gianolio E
    J Trace Elem Med Biol; 2018 Jul; 48():239-245. PubMed ID: 29773187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents.
    Suzuki H; Teranishi M; Sone M; Yamazaki M; Naganawa S; Nakashima T
    Acta Otolaryngol; 2011 Oct; 131(10):1025-31. PubMed ID: 21732744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
    Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
    Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy.
    Boyken J; Lohrke J; Treu A; Neddens J; Jost G; Ulbrich HF; Balzer T; Frenzel T; Prokesch M; Thuss U; Pietsch H
    Radiology; 2024 Jan; 310(1):e231984. PubMed ID: 38226877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
    Sze G; Brant-Zawadzki M; McNamara MT; Haughton VM; Kumar AJ; Maravilla KR; Aisen AM; Dreisbach JN; Bradley WG; Weinreb JC
    Invest Radiol; 1993 Mar; 28 Suppl 1():S49-55. PubMed ID: 8486504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of MRI contrast agents (Omniscan) on vestibular end organs.
    Tanaka H; Tanigawa T; Suzuki M; Otsuka K; Inafuku S
    Acta Otolaryngol; 2010; 130(1):17-24. PubMed ID: 19449223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of preclinical safety evaluation of gadoteridol injection.
    Soltys RA
    Invest Radiol; 1992 Aug; 27 Suppl 1():S7-11. PubMed ID: 1506157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere's disease.
    Fukuoka H; Tsukada K; Miyagawa M; Oguchi T; Takumi Y; Sugiura M; Ueda H; Kadoya M; Usami S
    Acta Otolaryngol; 2010; 130(1):10-6. PubMed ID: 19363714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic toxicity of the gadolinium chelates.
    Runge VM; Kuehl TJ; Jackson CB; Estrada EA
    Acad Radiol; 2005 May; 12 Suppl 1():S6-9. PubMed ID: 16106537
    [No Abstract]   [Full Text] [Related]  

  • 19. Vestibular and cochlear ototoxicity of topical antiseptics assessed by evoked potentials.
    Perez R; Freeman S; Sohmer H; Sichel JY
    Laryngoscope; 2000 Sep; 110(9):1522-7. PubMed ID: 10983954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent.
    Van Wagoner M; Worah D
    Invest Radiol; 1993 Mar; 28 Suppl 1():S44-8. PubMed ID: 8486503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.